17
Participants
Start Date
September 8, 2020
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Infusion of MCARH109 T cells
Patients will be admitted to Memorial Hospital as inpatient prior to the infusion of CAR T cells. The T cell infusion will be planned to start at 2 days following the completion of the conditioning chemotherapy (up to 7 days is allowed if clinically indicated to delay).Cohorts of 3-6 patients each will be treated with escalating doses of modified T cells.
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Nassau (Limited protocol activities), Uniondale
Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities), Commack
Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Memorial Sloan Kettering Cancer Center
OTHER